INS
1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE
Find entries where: INS
is present as a standalone ligand in 36 entries
as a non-polymer is covalently linked to polymer or other heterogen groups  2 entries
Chemical Component Summary | |
---|---|
Name | 1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE |
Synonyms | MYO-INOSITOL |
Identifiers | cyclohexane-1,2,3,4,5,6-hexol |
Formula | C6 H12 O6 |
Molecular Weight | 180.16 |
Type | NON-POLYMER |
Isomeric SMILES | C1(C(C(C(C(C1O)O)O)O)O)O |
InChI | InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6- |
InChIKey | CDAISMWEOUEBRE-GPIVLXJGSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 24 |
Chiral Atom Count | 0 |
Bond Count | 24 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB13178 |
---|---|
Name | Inositol |
Groups |
|
Description | Inositol is a collection of nine different stereoisomers but the name is usually used to describe only the most common type of inositol, myo-inositol. Myo-inositol is the cis-1,2,3,5-trans-4,6-cyclohexanehexol and it is prepared from an aqueous extract of corn kernels by precipitation and hydrolysis of crude phytate. These molecules have structural similarities to glucose and are involved in cellular signaling. It is considered a pseudovitamin as it is a molecule that does not qualify to be an essential vitamin because even though its presence is vital in the body, a deficiency in this molecule does not translate into disease conditions.[L2560] Inositol can be found as an ingredient of OTC products by Health Canada but all current product whose main ingredient is inositol are discontinued.[L1113] By the FDA, inositol is considered in the list of specific substances affirmed as generally recognized as safe (GRAS).[L2561] |
Synonyms |
|
Brand Names |
|
Indication | Inositol may be used in food without any limitation. As a drug, inositol is used as a nutrient supplement in special dietary foods and infant formula.[L2561] As it presents a relevant role in ensuring oocyte fertility, inositol has been studied for its use in the management of polycystic ovaries.[A32751] Inositol is also being researched for the treatment of diabetes,[A32766] prevention of metabolic syndrome,[A32768] aid agent for weight loss,[A32769] treatment of depression, psychiatric disorder and anxiety disorder[A32770] and for prevention of cancer.[A32771] |
Categories |
|
ATC-Code | A11HA07 |
CAS number | 87-89-8 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Sodium/myo-inositol cotransporter | MRAVLDTADIAIVALYFILVMCIGFFAMWKSNRSTVSGYFLAGRSMTWVT... | unknown | substrate |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682